In general, YAP and TAZ in tumours can be up-regulated by a wide scope of mechanisms, including amplification of the YAP gene, inactivation of the Hippo pathway, activating K-Ras mutations or interaction with other molecular pathways, including Notch, Wnt or TGFβ [66]. Here, KRAS is linked to neoplasm.